Search results
Results from the WOW.Com Content Network
Dual diagnosis (also called co-occurring disorders (COD) or dual pathology) [1] [2] is the condition of having a mental illness and a comorbid substance use disorder.There is considerable debate surrounding the appropriateness of using a single category for a heterogeneous group of individuals with complex needs and a varied range of problems.
The more recently published DSM-5 combined substance abuse and substance dependence into a single continuum; this is simply known as substance use disorder and requires more presenting symptoms before a diagnosis is made. It also considers each different substance as its own separate disorder, based upon the same basic criteria.
The DSM-5 criteria for somatic symptom disorder includes "one or more somatic symptoms which are distressing or result in substantial impairment of daily life." Additional criteria, often known as B criteria, include "excessive thoughts, feelings, or behaviors regarding somatic symptoms or corresponding health concerns manifested by ...
The most common comorbid disorders are depression and anxiety, [16] although cases of depersonalization disorder without symptoms of either do exist. Comorbid obsessive/compulsive behaviors may exist as attempts to deal with depersonalization, such as checking whether symptoms have changed and avoiding behavioral and cognitive factors that ...
For a diagnosis of DSM-5 cannabis use disorder, at least two of these criteria need to be present in the last twelve-month period. Additionally, three severity levels have been defined: mild (two or three criteria), moderate (four or five criteria) and severe (six or more criteria) cannabis use disorder. [43]
The Diagnostic and Statistical Manual of Mental Disorders (DSM; latest edition: DSM-5-TR, published in March 2022 [1]) is a publication by the American Psychiatric Association (APA) for the classification of mental disorders using a common language and standard criteria. It is an internationally accepted manual on the diagnosis and treatment of ...
A revision of DSM-5, titled DSM-5-TR, was published in March 2022, updating diagnostic criteria and ICD-10-CM codes. [52] The diagnostic criteria for avoidant/restrictive food intake disorder were changed, [ 53 ] [ 54 ] along with adding entries for prolonged grief disorder , unspecified mood disorder and stimulant-induced mild neurocognitive ...
Stimulant use disorder is a type of substance use disorder where the use of stimulants caused clinically significant impairment or distress. It is defined in the DSM-5 as "the continued use of amphetamine-type substances, cocaine, or other stimulants leading to clinically significant impairment or distress, from mild to severe". [1]